| Dr Michael Miller, DO | |
|
676 Wyoming Ave, Suite 104, Kingston, PA 18704-3857 | |
| (570) 287-1400 | |
| Not Available |
| Full Name | Dr Michael Miller |
|---|---|
| Gender | Male |
| Speciality | General Practice |
| Experience | 40 Years |
| Location | 676 Wyoming Ave, Kingston, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255394714 | NPI | - | NPPES |
| 001729923 | Medicaid | PA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | OS008632L (Pennsylvania) | Secondary |
| 208D00000X | General Practice | 05008632L (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Wilkes-barre General Hospital | Wilkes-barre, PA | Hospital |
| Geisinger Wyoming Valley Medical Center | Wilkes barre, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Debra T Miller Md Llc | 1355439530 | 2 |
News Archive
Celsion Corporation (Celsion) (NASDAQ: CLSN), an oncology drug development company, and EGEN, Inc. (EGEN), a privately-held biopharmaceutical company focused on the development of nucleic acid-based therapeutics for the treatment of cancer and other difficult to treat diseases, today announced the signing of a definitive asset purchase agreement in which Celsion will acquire substantially all of the assets of EGEN, including its Phase Ib DNA-based immunotherapy product candidate EGEN-001 and its therapeutic platform technologies, TheraPlas™ for delivery of DNA and mRNA, TheraSilence™ for delivery of RNA, and RAST™ for Cell Enabled Expression and Secretion of RNA.
London civil servants at the lower end of the employment scale and with lower social position were more likely to develop type 2 diabetes than those at higher employment levels, according to an article in the September 27 issue of the Archives of Internal Medicine, one of the JAMA/Archives journals.
The University of St. Augustine for Health Sciences plans to bring its Doctor of Physical Therapy program to Miami in fall 2015, pending accreditation and other regulatory approvals. The university, which has been a part of north Florida for more than 20 years, will open its new campus near the Dolphin Mall.
Researchers in Aberdeen have launched a study to see whether a new blood test can better predict the outcome for patients facing heart surgery.
Researchers have developed a three-dimensional 'organ on a chip' which enables real-time continuous monitoring of cells, and could be used to develop new treatments for disease while reducing the number of animals used in research.
› Verified 3 days ago
| Entity Name | Debra T Miller Md Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710176466 PECOS PAC ID: 1355439530 Enrollment ID: O20071126000109 |
News Archive
Celsion Corporation (Celsion) (NASDAQ: CLSN), an oncology drug development company, and EGEN, Inc. (EGEN), a privately-held biopharmaceutical company focused on the development of nucleic acid-based therapeutics for the treatment of cancer and other difficult to treat diseases, today announced the signing of a definitive asset purchase agreement in which Celsion will acquire substantially all of the assets of EGEN, including its Phase Ib DNA-based immunotherapy product candidate EGEN-001 and its therapeutic platform technologies, TheraPlas™ for delivery of DNA and mRNA, TheraSilence™ for delivery of RNA, and RAST™ for Cell Enabled Expression and Secretion of RNA.
London civil servants at the lower end of the employment scale and with lower social position were more likely to develop type 2 diabetes than those at higher employment levels, according to an article in the September 27 issue of the Archives of Internal Medicine, one of the JAMA/Archives journals.
The University of St. Augustine for Health Sciences plans to bring its Doctor of Physical Therapy program to Miami in fall 2015, pending accreditation and other regulatory approvals. The university, which has been a part of north Florida for more than 20 years, will open its new campus near the Dolphin Mall.
Researchers in Aberdeen have launched a study to see whether a new blood test can better predict the outcome for patients facing heart surgery.
Researchers have developed a three-dimensional 'organ on a chip' which enables real-time continuous monitoring of cells, and could be used to develop new treatments for disease while reducing the number of animals used in research.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michael Miller, DO 480 Pierce St, Ste 205, Kingston, PA 18704-5512 Ph: (570) 287-1400 | Dr Michael Miller, DO 676 Wyoming Ave, Suite 104, Kingston, PA 18704-3857 Ph: (570) 287-1400 |
News Archive
Celsion Corporation (Celsion) (NASDAQ: CLSN), an oncology drug development company, and EGEN, Inc. (EGEN), a privately-held biopharmaceutical company focused on the development of nucleic acid-based therapeutics for the treatment of cancer and other difficult to treat diseases, today announced the signing of a definitive asset purchase agreement in which Celsion will acquire substantially all of the assets of EGEN, including its Phase Ib DNA-based immunotherapy product candidate EGEN-001 and its therapeutic platform technologies, TheraPlas™ for delivery of DNA and mRNA, TheraSilence™ for delivery of RNA, and RAST™ for Cell Enabled Expression and Secretion of RNA.
London civil servants at the lower end of the employment scale and with lower social position were more likely to develop type 2 diabetes than those at higher employment levels, according to an article in the September 27 issue of the Archives of Internal Medicine, one of the JAMA/Archives journals.
The University of St. Augustine for Health Sciences plans to bring its Doctor of Physical Therapy program to Miami in fall 2015, pending accreditation and other regulatory approvals. The university, which has been a part of north Florida for more than 20 years, will open its new campus near the Dolphin Mall.
Researchers in Aberdeen have launched a study to see whether a new blood test can better predict the outcome for patients facing heart surgery.
Researchers have developed a three-dimensional 'organ on a chip' which enables real-time continuous monitoring of cells, and could be used to develop new treatments for disease while reducing the number of animals used in research.
› Verified 3 days ago
Dr. Stanley Michael Stanish, M.D. General Practice Medicare: Medicare Enrolled Practice Location: 675 Wyoming Ave, Kingston, PA 18704 Phone: 570-288-4205 | |
Dr. Joseph Anthony Campanella, M.D. General Practice Medicare: Not Enrolled in Medicare Practice Location: 675 Wyoming Ave, Kingston, PA 18704 Phone: 570-288-4205 |